Radiodermatitis
- May 2022
- 20min
Therapeutic classes inducing this adverse event
Radiotherapy
CTCAE V5.0
Faint erythema or dry desquamation
SIMPLIFIED GRADING
<10% BSA
Faint erythema or dry desquamation
References
Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.
CTCAE V5.0
Moderate to brisk erythema; patchy moist desquamation, mostly confined to skin folds and creases; moderate edema
SIMPLIFIED GRADING
Moderate to brisk erythema, moderate edema
Ulcerations and moist erosions confined to skin folds
References
Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.
CTCAE V5.0
Moist desquamation in areas other than skin folds and creases; bleeding induced by minor trauma and abrasion
SIMPLIFIED GRADING
Widespread moist ulcerations and erosions, extending beyond skin folds
Bleeding on minor trauma
References
Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.
CTCAE V5.0
Life-threatening consequences; skin necrosis or ulceration of full thickness dermis; spontaneous bleeding from involved site; skin graft indicated
SIMPLIFIED GRADING
Necrosis, ulceration of full thickness dermis
Spontaneous bleeding
References
Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.
Browse for more adverse events